[go: up one dir, main page]

CN116369249A - Construction method of zebra fish enteritis model - Google Patents

Construction method of zebra fish enteritis model Download PDF

Info

Publication number
CN116369249A
CN116369249A CN202310038701.3A CN202310038701A CN116369249A CN 116369249 A CN116369249 A CN 116369249A CN 202310038701 A CN202310038701 A CN 202310038701A CN 116369249 A CN116369249 A CN 116369249A
Authority
CN
China
Prior art keywords
zebrafish
construction method
intestinal
fructose
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202310038701.3A
Other languages
Chinese (zh)
Other versions
CN116369249B (en
Inventor
祝辉
廖大龙
王凝
兰朝华
肖雄俊
李林蔓
李璐
向元琳
阮茂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University of Science and Engineering
Original Assignee
Sichuan University of Science and Engineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University of Science and Engineering filed Critical Sichuan University of Science and Engineering
Priority to CN202310038701.3A priority Critical patent/CN116369249B/en
Publication of CN116369249A publication Critical patent/CN116369249A/en
Application granted granted Critical
Publication of CN116369249B publication Critical patent/CN116369249B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00Culture of aquatic animals
    • A01K61/10Culture of aquatic animals of fish
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/30Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving catalase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90283Oxidoreductases (1.) acting on superoxide radicals as acceptor (1.15)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention belongs to the field of animal models, and particularly discloses a method for constructing a zebra fish enteritis model. The light causes insufficient sleep, and can relate to the field of animal models, so that active oxygen is continuously accumulated in the intestinal tract, oxidative damage is caused to the intestinal tract, the barrier function of the intestinal tract is destroyed, and finally apoptosis of intestinal cells is caused. Meanwhile, after fructose enters the intestinal tract, the fructose is decomposed by fructokinase to cause endoplasmic reticulum stress and intestinal inflammation, so that the barrier of the intestinal tract is damaged, and the death rate of zebra fish is increased due to high concentration of fructose. Therefore, the invention adopts light to carry out sleep deprivation to increase the accumulation of the intestinal active oxygen, and simultaneously combines with low-concentration fructose solution to construct the zebra fish enteritis model. The method has the advantages of simple manufacturing process, low cost, wide popularization, strong modeling specificity, high model success rate and stable result, and can reduce the damage of the medicine to the zebra fish.

Description

斑马鱼肠炎模型的构建方法Construction method of zebrafish enteritis model

技术领域technical field

本发明涉及动物模型领域,具体公开了一种斑马鱼肠炎模型的构建方法。The invention relates to the field of animal models, and specifically discloses a method for constructing a zebrafish enteritis model.

背景技术Background technique

肠炎主要由于肠道屏障的失效,导致营养不良,从而使动物的生长性能和生产效率下降。当肠炎发生时,肠道机械屏障被破坏,包括杯状细胞减少和肠道紧密连接蛋白受损,大量有害细菌进入肠道并在肠中繁殖,产生粘膜炎症。随着进入肠道的有害细菌数量不断增加时,化学屏障功能将被破坏,微生物和内毒素会突破肠道屏障进入血液循环系统。Enteritis is mainly due to the failure of the intestinal barrier, leading to malnutrition, which reduces the growth performance and production efficiency of animals. When enteritis occurs, the intestinal mechanical barrier is destroyed, including the reduction of goblet cells and the damage of intestinal tight junction proteins, and a large number of harmful bacteria enter the intestinal tract and multiply in the intestinal tract, resulting in mucosal inflammation. As the number of harmful bacteria entering the intestinal tract continues to increase, the chemical barrier function will be destroyed, and microorganisms and endotoxins will break through the intestinal barrier and enter the blood circulation system.

现有肠炎模型构建方法主要有药物诱导和基因敲除。其中基因敲除费时费力,方法复杂,操作困难。而药物构建大多数采用DSS药物诱导肠炎的方法,都存在DSS浓度偏高,药物使用剂量高,成模效果不稳定。斑马鱼与其他模式动物(小鼠、大鼠等)不同,幼年斑马鱼一般采用全身浸泡的方法进行药物处理,而高浓度DSS浸泡建立斑马鱼肠炎的方法,会导致斑马鱼出现严重的全身炎症,容易导致死亡,增加消耗。The existing enteritis model construction methods mainly include drug induction and gene knockout. Among them, gene knockout is time-consuming, complicated and difficult to operate. However, most of the methods for drug construction using DSS drugs to induce enteritis have high DSS concentrations, high drug dosages, and unstable modeling effects. Zebrafish is different from other model animals (mice, rats, etc.), juvenile zebrafish are generally treated with drugs by whole-body immersion, and high-concentration DSS immersion to establish zebrafish enteritis will lead to severe systemic inflammation in zebrafish , easily lead to death and increase consumption.

鉴于此,特提出本发明。In view of this, the present invention is proposed.

发明内容Contents of the invention

为解决背景技术中的问题,本发明的目的提供一种试验周期短短、药物剂量低,方法简单、成模效果更好的斑马鱼肠炎模型的构建方法。In order to solve the problems in the background technology, the object of the present invention is to provide a method for constructing a zebrafish enteritis model with short test period, low drug dosage, simple method and better modeling effect.

为达到上述效果,本发明采用的技术方案为:In order to achieve the above-mentioned effect, the technical scheme adopted in the present invention is:

斑马鱼肠炎模型的构建方法,利用光照进行睡眠剥夺结合低浓度果糖溶液的方法处理诱导斑马鱼胚胎。The construction method of the zebrafish enteritis model is to induce zebrafish embryos by using light to perform sleep deprivation combined with low-concentration fructose solution.

优选的,所述斑马鱼胚胎挑选2-2.5 dpf发育正常的斑马鱼胚胎。Preferably, the zebrafish embryos selected are 2-2.5 dpf zebrafish embryos with normal development.

优选的,所述斑马鱼胚胎挑选2 dpf发育正常的斑马鱼胚胎。Preferably, the zebrafish embryos are selected from zebrafish embryos with normal development at 2 dpf.

优选的,所述利用光照进行睡眠剥夺结合低浓度果糖的具体方法为:将斑马鱼胚胎移入含有低浓度果糖溶液的胚胎培养水中,在28-28.5℃下实施强度为200-300lux不间断的光照进行睡眠剥夺培养,每隔22-24 h换液,培养3-3.5 d。Preferably, the specific method of using light to perform sleep deprivation combined with low-concentration fructose is: move zebrafish embryos into embryo culture water containing a low-concentration fructose solution, and implement uninterrupted light at an intensity of 200-300 lux at 28-28.5°C Perform sleep deprivation culture, change the medium every 22-24 h, and culture for 3-3.5 days.

优选的,将斑马鱼胚胎移入含有低浓度果糖溶液的胚胎培养水中,在28.5℃不间断的光照条件下进行睡眠剥夺培养,每隔24 h换液,培养3 d。Preferably, the zebrafish embryos are transferred into embryo culture water containing a low-concentration fructose solution, subjected to sleep deprivation culture at 28.5°C under uninterrupted light conditions, and the medium is changed every 24 h for 3 days.

优选的,所述低浓度果糖溶液的质量分数为1.0%-3.0%。Preferably, the mass fraction of the low-concentration fructose solution is 1.0%-3.0%.

优选的,所述低浓度果糖溶液的质量分数为2.0%。Preferably, the mass fraction of the low-concentration fructose solution is 2.0%.

优选的,所述斑马鱼为转基因标记品系。Preferably, the zebrafish is a transgenic marker strain.

本发明采用的另一技术方案为:Another technical scheme that the present invention adopts is:

上述任一所述构建方法得到的斑马鱼肠炎模型的的评估方法,包含以下(a)-(c)中任一种或多种:The evaluation method of the zebrafish enteritis model obtained by any of the construction methods described above includes any one or more of the following (a)-(c):

(a)利用荧光显微镜观察斑马鱼肠道中性粒聚集情况,同时利用ImageJ软件对肠道中性粒数量进行定量分析,并通过qPCR检测斑马鱼胚胎中相关炎症因子;(a) The aggregation of intestinal neutrophils in zebrafish was observed by fluorescence microscope, and the number of intestinal neutrophils was quantitatively analyzed by ImageJ software, and the relevant inflammatory factors in zebrafish embryos were detected by qPCR;

(b)利用荧光显微镜拍摄并结合DCFH-DA染色观察斑马鱼肠道内ROS生成量,并通过相应的酶活试剂盒检测斑马鱼胚胎的CAT和SOD酶活力以及MDA含量;(b) The amount of ROS production in the zebrafish intestine was observed by fluorescence microscopy and combined with DCFH-DA staining, and the CAT and SOD enzyme activities and MDA content of zebrafish embryos were detected by corresponding enzyme activity kits;

(c)斑马鱼肠道组织切片进行苏木素伊红(HE)染色观察斑马鱼肠道组织的病理情况。(c) Hematoxylin and eosin (HE) staining of zebrafish intestinal tissue sections to observe the pathological conditions of zebrafish intestinal tissue.

需要说明的是,本发明中,dpf为daypost-fertilization的缩写,是指斑马鱼受精几天后。It should be noted that, in the present invention, dpf is the abbreviation of daypost-fertilization, and refers to a few days after fertilization of zebrafish.

为了便于直观的观测斑马鱼肠道炎症情况,采用转基因标记的斑马鱼品系Tg(lyz:Dsred)观察肠道中性粒聚集情况。In order to observe the intestinal inflammation of zebrafish intuitively, the transgenic marked zebrafish line Tg (lyz: Dsred) was used to observe the accumulation of neutrophils in the intestine.

与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:

1.本发明的采用光照进行睡眠剥夺增加肠道活性氧的积累,同时加上低浓度的果糖溶液结合处理构建斑马鱼肠炎模型。该方法试验周期短,稳定性好,操作简单,便于观察,可广泛推广,造模特异性强,模型成功率高,结果稳定,可减少药物对斑马鱼的伤害;1. In the present invention, sleep deprivation by light is used to increase the accumulation of reactive oxygen species in the intestine, and at the same time, a low-concentration fructose solution is combined with treatment to construct a zebrafish enteritis model. This method has short test period, good stability, simple operation, easy observation, can be widely promoted, has strong modeling specificity, high model success rate, stable results, and can reduce the damage of drugs to zebrafish;

2.药物剂量低,成模时间更短效果更好;2. Low drug dose, shorter molding time and better effect;

3.该模型适用于各种预防和治疗肠炎疾病的药物筛选。3. The model is suitable for drug screening for various prevention and treatment of enteritis diseases.

附图说明Description of drawings

图1为实施例1中实验组、对照组、对比例1-2对斑马鱼肠道中性粒聚集情况的影响;其中A为白光和荧光显微镜结合下中性粒聚集表型图;B斑马鱼肠道处中性粒的定量图;Figure 1 is the effect of the experimental group, control group, and comparative examples 1-2 on the aggregation of neutrophils in the intestinal tract of zebrafish in Example 1; wherein A is the phenotype diagram of neutrophil aggregation under the combination of white light and fluorescence microscopy; B zebrafish Quantitative map of neutrophils in the gut;

图2为实施例1中实验组、对照组、对比例1-2对斑马鱼胚胎炎症因子水平的影响;其中A为斑马鱼胚胎中IL-1β基因表达情况;B斑马鱼胚胎中TNF-α基因表达情况;Fig. 2 is the influence of experimental group, control group, comparative example 1-2 on zebrafish embryo inflammatory factor level in embodiment 1; Wherein A is IL-1β gene expression situation in zebrafish embryo; B TNF-α in zebrafish embryo Gene expression status;

图3为实施例1中实验组、对照组、对比例1-2斑马鱼肠道ROS生成量的的影响;图中为拍摄的斑马鱼肠道,其中成片明亮代表肠道活性氧积累强度,点状分布代表肠道中性粒富集情况;Figure 3 is the effect of the experimental group, control group, and comparative example 1-2 zebrafish intestinal ROS production in Example 1; the figure is the photographed zebrafish intestinal tract, and the bright patches represent the accumulation intensity of active oxygen in the intestinal tract , the dotted distribution represents the enrichment of intestinal neutrophils;

图4为实施例1中实验组、对照组、对比例1-2对斑马鱼胚胎氧化应激的影响;其中左上的分图为斑马鱼胚胎中SOD酶活力(U/mgprot);右上的分图为斑马鱼胚胎中CAT酶活力(U/mgprot);左下的分图为斑马鱼胚胎中MDA含量(nmol/mgpr);Fig. 4 is the influence of experimental group, control group, comparative example 1-2 on the oxidative stress of zebrafish embryo in embodiment 1; Wherein upper left subgraph is SOD enzyme activity (U/mgprot) in zebrafish embryo; The picture shows the activity of CAT enzyme in zebrafish embryos (U/mgprot); the sub-picture on the lower left shows the content of MDA in zebrafish embryos (nmol/mgpr);

图5为实施例1中实验组、对照组、对比例1-2中斑马鱼肠道组织切片HE染色图;其中A为斑马鱼肠道的横切面;其中B为斑马鱼肠道的纵切面。Fig. 5 is the HE staining diagram of the zebrafish intestinal tissue section in the experimental group, the control group, and comparative examples 1-2 in Example 1; wherein A is the cross section of the zebrafish intestinal tract; wherein B is the longitudinal section of the zebrafish intestinal tract .

具体实施方法Specific implementation method

为更好地理解本发明的技术方案,下面将结合附图和实施例对本发明的技术方案作进一步说明。实现本发明的方式包括但不仅限于以下实施例,以下实施例用于说明本发明,但不用来限定本发明的保护范围。若未特别指明,实施例中所用技术手段为本领域技术人员所熟知的常规手段。下述实施例中的试验方法,如无特别说明,均为常规方法。In order to better understand the technical solution of the present invention, the technical solution of the present invention will be further described below in conjunction with the drawings and embodiments. The way to realize the present invention includes but not limited to the following examples, the following examples are used to illustrate the present invention, but not to limit the protection scope of the present invention. Unless otherwise specified, the technical means used in the embodiments are conventional means well known to those skilled in the art. The test methods in the following examples are conventional methods unless otherwise specified.

实施例1 用于详细说明斑马鱼肠炎模型的构建方法Example 1 is used to describe the construction method of the zebrafish enteritis model in detail

1实验方法1 Experimental method

1.1、将正常养殖的斑马鱼按雄性和雌性以1:1或1:2的个数比放入交配缸中,并用隔板隔开。第二天早上,移除屏障,雌性开始产卵。产卵后30min内采集胚胎,并且吸出死亡和未受精的卵、粪便等杂物后用清水冲洗3次。然后置于28.5℃培养箱。1.1. Put the normally cultured zebrafish into the mating tank at a ratio of 1:1 or 1:2 for males and females, and separate them with partitions. The next morning, the barrier is removed and the females begin laying eggs. Embryos were collected within 30 minutes after spawning, and dead and unfertilized eggs, feces and other debris were sucked out and rinsed with clean water 3 times. Then place in a 28.5°C incubator.

1.2、显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,设置2个组,每组20-25个胚胎对挑选的胚胎进行不同的处理后置于28.5℃恒温培养箱中培养3 d,每隔22-24 h换液,2个组具体设置为:1.2. Select 2 dpf transgenic Tg (lyz: Dsred) zebrafish embryos with normal development under the microscope, set up 2 groups, 20-25 embryos in each group, carry out different treatments on the selected embryos and place them in a constant temperature incubator at 28.5°C Cultivate for 3 days, change the medium every 22-24 hours, and the specific settings of the two groups are as follows:

对照组:8ml的胚胎培养水,光照强度25lux,光暗循环条件在14h黑暗:10h光照;Control group: 8ml of embryo culture water, light intensity 25lux, light-dark cycle conditions: 14h dark: 10h light;

实验组(光照睡眠剥夺+果糖组):8ml体积质量分数2.0%的果糖培养水,在200-300lux光照条件下培养,不间断地持续光照。Experimental group (light sleep deprivation + fructose group): 8ml of fructose culture water with a volume mass fraction of 2.0%, cultured under 200-300lux light conditions, and continued light without interruption.

1.3、利用荧光显微镜(德国莱卡M205FA)观察处理后的转基因Tg(lyz:Dsred)斑马鱼肠道处中性粒聚集情况。同时进一步利用ImageJ软件对肠道中性粒数量进行定量分析,并通过qPCR检测斑马鱼胚胎中相关炎症因子,如白细胞介素1β(IL-1β)和肿瘤坏死因子-α(TNF-α)的转录水平。1.3. Use a fluorescence microscope (Leica M205FA, Germany) to observe the aggregation of neutrophils in the intestinal tract of transgenic Tg (lyz: Dsred) zebrafish after treatment. At the same time, ImageJ software was further used to quantitatively analyze the number of intestinal neutrophils, and qPCR was used to detect the transcription of related inflammatory factors in zebrafish embryos, such as interleukin 1β (IL-1β) and tumor necrosis factor-α (TNF-α). level.

1.4、利用荧光显微镜拍摄并结合DCFH-DA染色观察斑马鱼肠道内ROS生成量,并通过相应的酶活试剂盒检测斑马鱼胚胎的CAT和SOD酶活力以及MDA含量。1.4. Use fluorescent microscope to shoot and combine with DCFH-DA staining to observe the amount of ROS production in the zebrafish intestine, and use the corresponding enzyme activity kit to detect the CAT and SOD enzyme activities and MDA content of zebrafish embryos.

1.5、将1.2中处理后的斑马鱼用质量分数为4%的多聚甲醛溶液(PFA)固定约24 h后,然后在体积分数为70%的乙醇水溶液中脱水5次,4-5 min/次;然后分别在体积分数为80%、90%、100%的梯度乙醇水溶液中各脱水1次,4-5 min/次,完成脱水;1.5. Fix the zebrafish treated in 1.2 with 4% paraformaldehyde solution (PFA) for about 24 h, and then dehydrate in 70% ethanol aqueous solution for 5 times, 4-5 min/ and then dehydration in gradient ethanol aqueous solution with a volume fraction of 80%, 90%, and 100% respectively, 4-5 min/time, to complete the dehydration;

在完成脱水后,使用0.5ml二甲苯与0.5ml无水乙醇混合溶液穿透脱水后的斑马鱼组织15-20 min,然后在1ml的纯二甲苯中穿透斑马鱼组织7-10min,完成穿透处理;After the dehydration is completed, use a mixed solution of 0.5ml xylene and 0.5ml absolute ethanol to penetrate the dehydrated zebrafish tissue for 15-20 minutes, and then penetrate the zebrafish tissue in 1ml of pure xylene for 7-10 minutes to complete the penetration. Permeable treatment;

将完成穿透处理的斑马鱼组织置于0.5ml二甲苯与0.5ml石蜡混合溶液中并在约65℃烘箱中蜡浸25-30 min,然后换成1ml纯石蜡溶液在约65℃烘箱中浸蜡2-2.5 h,将组织取出封蜡于蜡盘中至少24 h后,切片(6um厚)并烘干;Put the zebrafish tissue that has been penetrated into a mixed solution of 0.5ml xylene and 0.5ml paraffin and soak it in an oven at about 65°C for 25-30 minutes, then change to 1ml pure paraffin solution and soak it in an oven at about 65°C Wax for 2-2.5 h, take out the tissue and put it in the wax dish for at least 24 h, slice it (6um thick) and dry it;

对烘干后的切片使用苏木精伊红(HE)染色,染色后用中性树脂密封并烘干后,使用蔡司显微镜拍照和观察切片中肠道内组织的变化情况。The dried sections were stained with hematoxylin and eosin (HE), sealed with neutral resin after staining and dried, then photographed and observed the changes of the intestinal tissues in the sections with a Zeiss microscope.

2.实验结果2. Experimental results

(a)光照睡眠剥夺和果糖溶液结合处理对斑马鱼肠道中性粒细胞富集的影响(a) Effects of combination treatment of light sleep deprivation and fructose solution on neutrophil enrichment in zebrafish gut

结果如图1所示,在光照睡眠剥夺+果糖组中观察到斑马鱼肠道处有显著的中性粒聚集情况,并且与单独的果糖组(对比例1)和单独的光照睡眠剥夺组(对比例2)相比,中性粒数据聚集更显著(图1A,B)。此外,如图2所示进一步通过qPCR检测斑马鱼胚胎中相关炎症因子的转录水平结果显示光照睡眠剥夺+果糖组的TNF-α和IL-1β的基因表达水平显著高于单独的果糖组(对比例1)和单独的光照睡眠剥夺组(对比例2)(图2A,B)。The results are shown in Figure 1. Significant neutrophil aggregation was observed in the zebrafish gut in the light sleep deprivation + fructose group, and it was compared with the fructose alone group (comparative example 1) and the light sleep deprivation group alone ( Compared with Comparative Example 2), the clustering of neutrophil data was more significant (Fig. 1A,B). In addition, as shown in Figure 2, further detection of the transcript levels of relevant inflammatory factors in zebrafish embryos by qPCR showed that the gene expression levels of TNF-α and IL-1β in the light sleep deprivation + fructose group were significantly higher than those in the fructose alone group (for Ratio 1) and the light sleep deprivation group alone (Comparative Ratio 2) (Fig. 2A,B).

(b)光照睡眠剥夺和果糖溶液结合处理对斑马鱼肠道氧化应激和活性氧水平的影响(b) Effects of light sleep deprivation and fructose solution combined treatment on oxidative stress and reactive oxygen species levels in zebrafish gut

结果如图3所示,进一步利用荧光显微镜拍摄和结合DCFH-DA染色结合发现光照睡眠剥夺+果糖组中斑马鱼肠道内ROS生成量明显高于单独果糖组(对比例1)和光照睡眠剥夺组(对比例2)(图3)。并且,如图4所示,通过相应的酶活试剂盒检测斑马鱼胚胎的CAT和SOD酶活力以及MDA含量,结果显示光照睡眠剥夺+果糖组中斑马鱼胚胎体内的CAT和SOD酶活显著低于单独果糖组(对比例1)和光照睡眠剥夺组(对比例2),而MDA含量显著高于单独果糖组(对比例1)和光照睡眠剥夺组(对比例2)(图4)。表明光照睡眠剥夺+果糖结合处理会导致斑马鱼肠道产生更明显的氧化应激反应和活性氧积累。The results are shown in Figure 3. Further use of fluorescence microscopy and DCFH-DA staining combined to find that the ROS production in the zebrafish gut in the light sleep deprivation + fructose group was significantly higher than that in the fructose alone group (Comparative Example 1) and the light sleep deprivation group (Comparative Example 2) (Fig. 3). Moreover, as shown in Figure 4, the CAT and SOD enzyme activities and MDA content of zebrafish embryos were detected by corresponding enzyme activity kits, and the results showed that the CAT and SOD enzyme activities in zebrafish embryos in the light sleep deprivation + fructose group were significantly lower Compared with the fructose alone group (comparative example 1) and the light sleep deprivation group (comparative example 2), the MDA content was significantly higher than the single fructose group (comparative example 1) and the light sleep deprivation group (comparative example 2) (Figure 4). It was shown that light sleep deprivation + fructose combination treatment would lead to more obvious oxidative stress response and reactive oxygen species accumulation in the zebrafish gut.

(c)光照睡眠剥夺和果糖溶液结合处理对斑马鱼肠道组织结构的影响(c) Effects of combination treatment of light sleep deprivation and fructose solution on the intestinal structure of zebrafish

结果如图5所示,为了观察斑马鱼肠道组织病理情况,对肠道分别进行横切和纵切以及后续的HE染色,结果显示单独的果糖组(对比例1)和光照睡眠剥夺组(对比例2)均能使斑马鱼肠道内的肠绒毛变稀疏,变短。但光照睡眠剥夺+果糖结合处理组此现象愈发严重,肠道内甚至呈现一种糜烂状(图5A,B)。The results are shown in Figure 5. In order to observe the histopathological conditions of the intestinal tract of zebrafish, cross-section and longitudinal section and subsequent HE staining were performed on the intestinal tract respectively. Comparative example 2) can make the intestinal villi in the intestine of zebrafish thinner and shorter. However, this phenomenon was more severe in the light sleep deprivation + fructose combination treatment group, and the intestinal tract even showed a kind of erosion (Fig. 5A, B).

对比例1Comparative example 1

一种斑马鱼肠炎模型的构建方法,将实施例1中1.2的光照睡眠剥夺+果糖组替换为只加入质量分数2.0%果糖溶液处理3 d,即单独的果糖组。具体为:A method for constructing a zebrafish enteritis model, in which the light sleep deprivation + fructose group in 1.2 of Example 1 is replaced by only adding 2.0% fructose solution for 3 days, that is, the fructose alone group. Specifically:

显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,移入8ml的用胚胎培养水配置的质量分数为2.0%的果糖溶液中并置于28.5℃恒温培养箱中培养3 d,每隔22-24 h换液,单独的果糖组(胚胎培养水配置的质量分数为2.0%的果糖溶液,光照强度25lux,光暗循环条件在14h黑暗:10h光照)。Transgenic Tg (lyz:Dsred) zebrafish embryos with normal development at 2 dpf were selected under a microscope, transferred into 8 ml of fructose solution with a mass fraction of 2.0% in embryo culture water and placed in a constant temperature incubator at 28.5°C for 3 days. The medium was changed every 22-24 h, and the fructose group alone (embryo culture water was prepared with 2.0% fructose solution, the light intensity was 25 lux, and the light-dark cycle condition was 14h dark: 10h light).

对比例2Comparative example 2

一种斑马鱼肠炎模型的构建方法,将实施例1中1.2的光照睡眠剥夺+果糖组替换为只用200-300lux光照强度持续光照3d进行睡眠剥夺,即单独的光照睡眠剥夺组。具体为:A method for constructing a zebrafish enteritis model, replacing the light sleep deprivation + fructose group in 1.2 of Example 1 with only 200-300 lux light intensity and continuous light for 3 days for sleep deprivation, that is, the light sleep deprivation group alone. Specifically:

显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,移入8ml的胚胎培养水并置于温度28.5℃、200-300lux光照条件的恒温培养箱中进行培养,每隔22-24 h换液,不间断地持续光照3d。Under the microscope, 2 dpf transgenic Tg (lyz: Dsred) zebrafish embryos with normal development were selected, transferred to 8ml of embryo culture water, and placed in a constant temperature incubator with a temperature of 28.5°C and 200-300lux light conditions for cultivation. Every 22-24 h, change the liquid, and continue to illuminate for 3 days without interruption.

对比例3Comparative example 3

一种斑马鱼肠炎模型的构建方法,将实施例1中1.2的光照睡眠剥夺+果糖组替换为只用质量分数3.0%果糖溶液处理3.5d。具体为:A method for constructing a zebrafish enteritis model, replacing the light sleep deprivation + fructose group of 1.2 in Example 1 with only 3.0% fructose solution for 3.5 days. Specifically:

显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,移入8ml的用胚胎培养水配置的质量分数为3.0%的果糖溶液中并置于温度28.5℃、25lux光照条件的恒温培养箱中培养3.5 d,每隔22-24 h换液,光暗循环条件在14h黑暗:10h光照。Select 2 dpf transgenic Tg (lyz:Dsred) zebrafish embryos with normal development under a microscope, transfer them into 8ml fructose solution with a mass fraction of 3.0% prepared with embryo culture water, and place them in constant temperature culture at 28.5°C and 25lux light conditions Cultivate in the box for 3.5 days, change the medium every 22-24 hours, and the light-dark cycle condition is 14h dark: 10h light.

对比例4Comparative example 4

一种斑马鱼肠炎模型的构建方法,将实施例1中1.2的光照睡眠剥夺+果糖组替换为只用200-300lux光照强度持续光照3.5d进行睡眠剥夺。具体为:A method for constructing a zebrafish enteritis model, in which the light sleep deprivation + fructose group in 1.2 of Example 1 is replaced with only 200-300 lux light intensity and continuous light for 3.5 days for sleep deprivation. Specifically:

显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,移入8ml的用胚胎培养水并置于温度28.5℃、200-300lux光照条件的恒温培养箱中进行培养,每隔22-24h换液,不间断地持续光照3.5d。Under the microscope, 2 dpf transgenic Tg (lyz: Dsred) zebrafish embryos with normal development were selected, transferred to 8ml of embryo culture water and placed in a constant temperature incubator with a temperature of 28.5°C and 200-300lux light conditions for cultivation. Every 22- The medium was changed every 24 hours, and the light continued for 3.5 days without interruption.

实施例2Example 2

一种斑马鱼肠炎模型的构建方法,将实施例1中1.2的光照睡眠剥夺+果糖组中的果糖浓度降低为质量分数1.0%的果糖培养水处理3d。具体为:A method for constructing a zebrafish enteritis model, in which the fructose concentration in the light sleep deprivation+fructose group of 1.2 in Example 1 is reduced to 1.0% fructose culture water for 3 days. Specifically:

显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,移入8ml的用胚胎培养水配置的质量分数为1.0%的果糖溶液中并置于温度28.5℃、200-300lux光照条件的恒温培养箱中进行培养,每隔22-24 h换液,不间断的持续光照3d。其余操作均与实施例1相同。Select 2 dpf transgenic Tg (lyz:Dsred) zebrafish embryos with normal development under a microscope, transfer them into 8 ml of fructose solution with a mass fraction of 1.0% prepared in embryo culture water, and place them in a 28.5°C, 200-300lux light conditions. The culture was carried out in a constant temperature incubator, the medium was changed every 22-24 h, and the light was continuously illuminated for 3 days. All the other operations are the same as in Example 1.

实施例3Example 3

一种斑马鱼肠炎模型的构建方法,将实施例1中1.2的光照睡眠剥夺+果糖组中的果糖浓度提高为质量分数3.0%的果糖培养水处理3d。具体为:A method for constructing a zebrafish enteritis model. The fructose concentration in the light sleep deprivation+fructose group of 1.2 in Example 1 is increased to 3.0% fructose culture water for 3 days. Specifically:

显微镜下挑选2 dpf发育正常的转基因Tg(lyz:Dsred)斑马鱼胚胎,移入8ml的用胚胎培养水配置的质量分数为3.0%的果糖溶液中并置于温度28.5℃、200-300lux光照条件的恒温培养箱中进行培养,每隔22-24 h换液,不间断的持续光照3d。其余操作均与实施例1相同。Select 2 dpf transgenic Tg (lyz:Dsred) zebrafish embryos with normal development under a microscope, transfer them into 8ml of fructose solution with a mass fraction of 3.0% prepared in embryo culture water, and place them in a 28.5°C, 200-300lux light conditions. The culture was carried out in a constant temperature incubator, the medium was changed every 22-24 h, and the light was continuously illuminated for 3 days. All the other operations are the same as in Example 1.

表1各组肠炎模型诱变率和斑马鱼胚胎死亡率Table 1 The mutagenesis rate and zebrafish embryonic mortality of enteritis model in each group

Figure SMS_1
Figure SMS_1
.

最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,但本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。It should be noted that at last: above each embodiment is only in order to illustrate technical scheme of the present invention, and is not intended to limit; Although the present invention has been described in detail with reference to foregoing each embodiment, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present invention. range.

Claims (10)

1.斑马鱼肠炎模型的构建方法,其特征在于,利用光照进行睡眠剥夺结合低浓度果糖溶液的方法处理诱导斑马鱼胚胎。1. The construction method of the zebrafish enteritis model is characterized in that, utilizing light to carry out sleep deprivation combined with the method of low-concentration fructose solution to process and induce zebrafish embryos. 2.如权利要求1所述的构建方法,其特征在于,所述斑马鱼胚胎挑选2-2.5 dpf发育正常的斑马鱼胚胎。2. The construction method according to claim 1, wherein the zebrafish embryos are selected from zebrafish embryos with normal development of 2-2.5 dpf. 3.如权利要求2所述的构建方法,其特征在于,所述斑马鱼胚胎挑选2 dpf发育正常的斑马鱼胚胎。3. The construction method according to claim 2, wherein the zebrafish embryos are selected from zebrafish embryos with normal development at 2 dpf. 4.如权利要求1所述的构建方法,其特征在于,所述利用光照进行睡眠剥夺结合低浓度果糖的具体方法为:将斑马鱼胚胎移入含有低浓度果糖溶液的胚胎培养水中,在28-28.5℃下实施强度为200-300lux不间断的光照进行睡眠剥夺培养,每隔22-24 h换液,培养3-3.5d。4. The construction method according to claim 1, characterized in that, the specific method of utilizing light to carry out sleep deprivation in combination with low-concentration fructose is: moving zebrafish embryos into embryo culture water containing low-concentration fructose solution, at 28- Under 28.5°C, the intensity of 200-300lux uninterrupted light was implemented for sleep deprivation culture, and the medium was changed every 22-24 h, and the culture was 3-3.5d. 5.如权利要求4所述的构建方法,其特征在于,将斑马鱼胚胎移入含有低浓度果糖溶液的胚胎培养水中,在28-28.5℃不间断的光照条件下进行睡眠剥夺培养,每隔24 h换液,培养3 d。5. The construction method according to claim 4, wherein the zebrafish embryos are moved into embryo culture water containing a low-concentration fructose solution, and sleep deprivation is carried out at 28-28.5°C under uninterrupted light conditions, and every 24 Change the medium for 3 h and culture for 3 d. 6.如权利要求1或3所述的构建方法,其特征在于,所述低浓度果糖溶液的质量分数为1.0%-3.0%。6. The construction method according to claim 1 or 3, wherein the mass fraction of the low-concentration fructose solution is 1.0%-3.0%. 7.如权利要求6所述的构建方法,其特征在于,所述低浓度果糖溶液的质量分数为2.0%。7. The construction method according to claim 6, wherein the mass fraction of the low-concentration fructose solution is 2.0%. 8.如权利要求1所述的构建方法,其特征在于,所述斑马鱼为转基因标记品系。8. The construction method according to claim 1, wherein the zebrafish is a transgenic marker strain. 9.如权利要求8所述的构建方法,其特征在于,所述转基因标记品系为Tg(lyz:Dsred)。9. The construction method according to claim 8, wherein the transgenic marker line is Tg (lyz: Dsred). 10.如权利要求1-9任一所述构建方法得到的斑马鱼肠炎模型的评估方法,其特征在于,包含以下(a)-(c)中任一种或多种:10. The evaluation method of the zebrafish enteritis model obtained by the construction method according to any one of claims 1-9, characterized in that, comprising any one or more of the following (a)-(c): (a)利用荧光显微镜观察斑马鱼肠道中性粒聚集情况,同时利用ImageJ软件对肠道中性粒数量进行定量分析,并通过qPCR检测斑马鱼胚胎中相关炎症因子;(a) The aggregation of intestinal neutrophils in zebrafish was observed by fluorescence microscope, and the number of intestinal neutrophils was quantitatively analyzed by ImageJ software, and the relevant inflammatory factors in zebrafish embryos were detected by qPCR; (b)利用荧光显微镜拍摄并结合DCFH-DA染色观察斑马鱼肠道内ROS生成量,并通过相应的酶活试剂盒检测斑马鱼胚胎的CAT和SOD酶活力以及MDA含量;(b) The amount of ROS production in the zebrafish intestine was observed by fluorescence microscopy and combined with DCFH-DA staining, and the CAT and SOD enzyme activities and MDA content of zebrafish embryos were detected by corresponding enzyme activity kits; (c)斑马鱼肠道组织切片进行苏木素伊红(HE)染色观察斑马鱼肠道组织的病理情况。(c) Hematoxylin and eosin (HE) staining of zebrafish intestinal tissue sections to observe the pathological conditions of zebrafish intestinal tissue.
CN202310038701.3A 2023-01-13 2023-01-13 Method for constructing a zebrafish enteritis model Active CN116369249B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310038701.3A CN116369249B (en) 2023-01-13 2023-01-13 Method for constructing a zebrafish enteritis model

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310038701.3A CN116369249B (en) 2023-01-13 2023-01-13 Method for constructing a zebrafish enteritis model

Publications (2)

Publication Number Publication Date
CN116369249A true CN116369249A (en) 2023-07-04
CN116369249B CN116369249B (en) 2024-05-17

Family

ID=86964482

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310038701.3A Active CN116369249B (en) 2023-01-13 2023-01-13 Method for constructing a zebrafish enteritis model

Country Status (1)

Country Link
CN (1) CN116369249B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115786246A (en) * 2022-12-16 2023-03-14 四川轻化工大学 Construction method of zebrafish immune unresponsive heart failure model
CN119404809A (en) * 2024-12-10 2025-02-11 南京医科大学第二附属医院 A method for constructing a zebrafish sepsis model and its application

Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294074A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
KR20060006522A (en) * 2004-07-16 2006-01-19 김동민 Composition having tobacco purifying effect and tobacco purifying card using the composition
US20060233709A1 (en) * 2003-01-28 2006-10-19 Paul Goldsmith Method for identifying novel treatments of inflammatory disease in the gut
CN101965811A (en) * 2010-06-18 2011-02-09 赵林斌 Method for treating enteritis disease of grass carp parent fishes
KR20110054952A (en) * 2009-11-19 2011-05-25 영남대학교 산학협력단 Zebrafish Model for Inflammatory Disease and Screening Method of Anti-inflammatory Agent Using the Same
CN103598147A (en) * 2013-10-15 2014-02-26 东北林业大学 Method for screening related genes of fruit fly intestinal immunity
CA2962757A1 (en) * 2014-09-26 2016-03-31 National University Of Singapore Methods and compositions for modulating th-gm cell function
KR101706598B1 (en) * 2015-11-20 2017-02-15 인제대학교 산학협력단 Composition comprising water-soluble fructooligosaccharide calcium for preventing or treating bone disease and joint disease
KR20170042417A (en) * 2015-10-08 2017-04-19 영남대학교 산학협력단 Method for oxidative stress model using hydrogen peroxide and antioxidant screening method using the same
FR3050614A1 (en) * 2016-04-29 2017-11-03 Univ Sichuan Agricultural METHOD FOR ESTABLISHING A GOSSYPOL INDUCED FISH ENTERTAINMENT MODEL
FR3050615A1 (en) * 2016-04-29 2017-11-03 Univ Sichuan Agricultural METHOD FOR ESTABLISHING AN ERUCIC ACID INDUCED FISH ENTERTAINMENT MODEL
WO2017198847A1 (en) * 2016-05-20 2017-11-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treating microbiome dysregulations associated with circadian clock disruption
CN107636146A (en) * 2015-03-02 2018-01-26 同生公司 It is engineered to treat the bacterium of the disease for the gastrointestinal mucosal barrier benefited from the alimentary canal inflammation of reduction and/or tightened up
US20180303743A1 (en) * 2016-02-23 2018-10-25 Hangzhou Redox Pharmatech Co., Ltd. Novel recombinant high-stability superoxide dismutase and application thereof
KR101935199B1 (en) * 2018-06-04 2019-01-03 제주대학교 산학협력단 Composition Containning Diphlorethohydroxycarmalol for Improvement of Exercise Performance
WO2019010254A1 (en) * 2017-07-07 2019-01-10 President And Fellows Of Harvard College A method for treating damage induced by sleep deprivation
CN110215513A (en) * 2018-11-15 2019-09-10 北京诺思兰德生物技术股份有限公司 Purposes of the modified extrasin beta 4 in terms of therapeutic radiation enteritis
KR20200064432A (en) * 2018-11-29 2020-06-08 인하대학교 산학협력단 A preparation method for animal model of alzheimer's disease and animal model of alzheimer's disease using the same
KR20200064430A (en) * 2018-11-29 2020-06-08 인하대학교 산학협력단 Pharmaceutical composition for treating learning and memory disorder induced by sleep disturbance
CN112245596A (en) * 2020-11-09 2021-01-22 浙江大学 A method for screening pharmacodynamic substances based on zebrafish inflammatory bowel disease model
CN112450330A (en) * 2019-09-06 2021-03-09 中国科学院水生生物研究所 Application of sinomenine in preventing and treating fish enterohepatitis caused by soybean meal feed
CN112655601A (en) * 2020-12-02 2021-04-16 中国水产科学研究院淡水渔业研究中心 Establishment and application of model for inducing freshwater fish acute liver and intestine combined injury by carbon tetrachloride
CN112870384A (en) * 2021-02-04 2021-06-01 山东省科学院生物研究所 Method for screening anti-Alzheimer's disease drugs based on behavior and biochemical indexes and drugs screened by method
CN112997926A (en) * 2020-12-17 2021-06-22 中国科学院水生生物研究所 Method for evaluating components for relieving food-borne enteritis based on zebra fish juvenile fish imaging model
WO2021135798A1 (en) * 2019-12-31 2021-07-08 南京大学 Application of mulberroside a and derivatives thereof in preparation of drugs for protecting intestinal barrier
WO2022121110A1 (en) * 2020-12-11 2022-06-16 中山大学附属第五医院 Mechanism based on gastrointestinal symptoms caused by sars-cov-2 and application therefor
CN114668816A (en) * 2022-02-23 2022-06-28 如新(中国)日用保健品有限公司 Composition containing dendrobium officinale extract and application thereof

Patent Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294074A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
US20060233709A1 (en) * 2003-01-28 2006-10-19 Paul Goldsmith Method for identifying novel treatments of inflammatory disease in the gut
KR20060006522A (en) * 2004-07-16 2006-01-19 김동민 Composition having tobacco purifying effect and tobacco purifying card using the composition
KR20110054952A (en) * 2009-11-19 2011-05-25 영남대학교 산학협력단 Zebrafish Model for Inflammatory Disease and Screening Method of Anti-inflammatory Agent Using the Same
CN101965811A (en) * 2010-06-18 2011-02-09 赵林斌 Method for treating enteritis disease of grass carp parent fishes
CN103598147A (en) * 2013-10-15 2014-02-26 东北林业大学 Method for screening related genes of fruit fly intestinal immunity
CA2962757A1 (en) * 2014-09-26 2016-03-31 National University Of Singapore Methods and compositions for modulating th-gm cell function
CN107636146A (en) * 2015-03-02 2018-01-26 同生公司 It is engineered to treat the bacterium of the disease for the gastrointestinal mucosal barrier benefited from the alimentary canal inflammation of reduction and/or tightened up
KR20170042417A (en) * 2015-10-08 2017-04-19 영남대학교 산학협력단 Method for oxidative stress model using hydrogen peroxide and antioxidant screening method using the same
KR101706598B1 (en) * 2015-11-20 2017-02-15 인제대학교 산학협력단 Composition comprising water-soluble fructooligosaccharide calcium for preventing or treating bone disease and joint disease
US20180303743A1 (en) * 2016-02-23 2018-10-25 Hangzhou Redox Pharmatech Co., Ltd. Novel recombinant high-stability superoxide dismutase and application thereof
FR3050614A1 (en) * 2016-04-29 2017-11-03 Univ Sichuan Agricultural METHOD FOR ESTABLISHING A GOSSYPOL INDUCED FISH ENTERTAINMENT MODEL
FR3050615A1 (en) * 2016-04-29 2017-11-03 Univ Sichuan Agricultural METHOD FOR ESTABLISHING AN ERUCIC ACID INDUCED FISH ENTERTAINMENT MODEL
WO2017198847A1 (en) * 2016-05-20 2017-11-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treating microbiome dysregulations associated with circadian clock disruption
WO2019010254A1 (en) * 2017-07-07 2019-01-10 President And Fellows Of Harvard College A method for treating damage induced by sleep deprivation
KR101935199B1 (en) * 2018-06-04 2019-01-03 제주대학교 산학협력단 Composition Containning Diphlorethohydroxycarmalol for Improvement of Exercise Performance
CN110215513A (en) * 2018-11-15 2019-09-10 北京诺思兰德生物技术股份有限公司 Purposes of the modified extrasin beta 4 in terms of therapeutic radiation enteritis
KR20200064432A (en) * 2018-11-29 2020-06-08 인하대학교 산학협력단 A preparation method for animal model of alzheimer's disease and animal model of alzheimer's disease using the same
KR20200064430A (en) * 2018-11-29 2020-06-08 인하대학교 산학협력단 Pharmaceutical composition for treating learning and memory disorder induced by sleep disturbance
CN112450330A (en) * 2019-09-06 2021-03-09 中国科学院水生生物研究所 Application of sinomenine in preventing and treating fish enterohepatitis caused by soybean meal feed
WO2021135798A1 (en) * 2019-12-31 2021-07-08 南京大学 Application of mulberroside a and derivatives thereof in preparation of drugs for protecting intestinal barrier
CN112245596A (en) * 2020-11-09 2021-01-22 浙江大学 A method for screening pharmacodynamic substances based on zebrafish inflammatory bowel disease model
CN112655601A (en) * 2020-12-02 2021-04-16 中国水产科学研究院淡水渔业研究中心 Establishment and application of model for inducing freshwater fish acute liver and intestine combined injury by carbon tetrachloride
WO2022121110A1 (en) * 2020-12-11 2022-06-16 中山大学附属第五医院 Mechanism based on gastrointestinal symptoms caused by sars-cov-2 and application therefor
CN112997926A (en) * 2020-12-17 2021-06-22 中国科学院水生生物研究所 Method for evaluating components for relieving food-borne enteritis based on zebra fish juvenile fish imaging model
CN112870384A (en) * 2021-02-04 2021-06-01 山东省科学院生物研究所 Method for screening anti-Alzheimer's disease drugs based on behavior and biochemical indexes and drugs screened by method
CN114668816A (en) * 2022-02-23 2022-06-28 如新(中国)日用保健品有限公司 Composition containing dendrobium officinale extract and application thereof

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
佚名: "《睡眠不足或通过在机体肠道中积累活性氧而导致死亡》", 《石河子科技》, no. 04, 31 August 2020 (2020-08-31), pages 37 *
吴之明等: "《护理学基础》", vol. 1, 31 July 2013, 同济大学出版社, pages: 208 *
李时杰;牛俊坤;缪应雷: "炎症性肠病动物模型研究进展", 中华炎性肠病杂志(中英文), vol. 3, no. 001, 31 December 2019 (2019-12-31), pages 21 - 24 *
池肇春等: "《肠道微生物与消化系统疾病》", vol. 1, 30 June 2020, 上海科学技术出版社, pages: 265 - 267 *
秦凯健等: "《低聚果糖影响结肠炎小鼠肠黏膜的研究》", 《免疫学杂志》, vol. 33, no. 11, 30 November 2017 (2017-11-30), pages 968 - 974 *
赵丽萍;黄术兵;张博枰;周芝兰;贾雪冰;孙孟菲;乔晨萌;陈雪;申延琴;崔春;: "鼠李糖乳杆菌对斑马鱼脊髓损伤后肠道炎症的抑制作用及其机制", 吉林大学学报(医学版), no. 04, 28 July 2020 (2020-07-28), pages 20 - 26 *
郭冶;卢凤美;刘东璞;: "肝纤维化发病机制及大黄酸对肝纤维化的作用", 医学信息, no. 12, 15 June 2020 (2020-06-15), pages 36 - 41 *
魏伟: "《药理研究方法学》", vol. 1, 31 May 2021, 中国医药科学技术出版社, pages: 350 - 352 *
黎明等: "《斑马鱼食源性肠炎模型及其免疫细胞成像分析方法的建立》", 《水生生物学报》, vol. 46, no. 02, 30 September 2021 (2021-09-30), pages 226 - 237 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115786246A (en) * 2022-12-16 2023-03-14 四川轻化工大学 Construction method of zebrafish immune unresponsive heart failure model
CN115786246B (en) * 2022-12-16 2024-09-06 四川轻化工大学 Method for constructing a zebrafish immune-unresponsive heart failure model
CN119404809A (en) * 2024-12-10 2025-02-11 南京医科大学第二附属医院 A method for constructing a zebrafish sepsis model and its application

Also Published As

Publication number Publication date
CN116369249B (en) 2024-05-17

Similar Documents

Publication Publication Date Title
Hinton et al. Liver structural alterations accompanying chronic toxicity in fishes: potential biomarkers of exposure
Grandel et al. Neural stem cells and neurogenesis in the adult zebrafish brain: origin, proliferation dynamics, migration and cell fate
CN116369249A (en) Construction method of zebra fish enteritis model
Qu et al. Ontogenetic development of the digestive system and growth in coral trout (Plectropomus leopardus)
CN104542389B (en) A kind of preparation method of non-alcoholic fatty liver zebrafish
CN106719114A (en) Cenospecies and production method between fugu obscurus and Fugu rubripes
Guo et al. Genetics of white color and iridophoroma in “Lemon Frost” leopard geckos
CN106667982A (en) Method for preparing zebrafish thrombus model
Amin et al. Budgett's frog (Lepidobatrachus laevis): A new amphibian embryo for developmental biology
CN104335970A (en) Method for building human psoriasis mouse model and application of model
Zhang et al. Intestinal barrier dysfunction induced by ammonia exposure in pigs in vivo and in vitro: The protective role of L-selenomethionine
Zhang et al. Artificial infection pathway of largemouth bass LMBV and identification of resistant and susceptible individuals
CN109642210A (en) A kind of manufacturing method of kidney
Gunay et al. Role of autophagy in midgut stem cells of silkworm Bombyx mori, during larval–pupal metamorphosis
CN116686781A (en) Construction method of inflammatory bowel disease with depression mouse model
CN114223613B (en) Mouse model for hypercholesterolemia and atherosclerosis based on AAV8-PCSK9 induction and construction method
Song et al. Establishment of a rotavirus-infected zebrafish model and its application in drug screening
Su et al. Effect of drought stress on the growth, ovary development, antioxidant capacity, sex hormone content, and reproductive-related gene expression of red swamp crayfish (Procambarus clarkii)
Akle et al. F-spondin/spon1b expression patterns in developing and adult zebrafish
CN112111554B (en) Method for evaluating anti-aging efficacy of cosmetics
Wislocki The staining of amphibian larvae with benzidine dyes with especial reference to the behavior of the lymphatic endothelium
Jerrett et al. Pathology of a Bohle-like virus infection in two Australian frog species (Litoria splendida and Litoria caerulea)
Capucchio et al. Natural trematode infestation in feral Nebrodi Black pigs: pathological investigations
Davison et al. Characterization of Kras‐mediated pancreatic tumorigenesis in zebrafish
CN103695539A (en) Method for detecting toxicity of nonyl phenol through in vitro culture of genital gland of silkworm

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant